Citizen Portal
Sign In

Judiciary committee approves privacy protections for health-care merger filings

Joint Standing Committee on the Judiciary (Maine Legislature) · March 31, 2026

Loading...

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Judiciary committee unanimously approved two committee-backed measures: LD2202 requires pre-merger Hart-Scott-Rodino notices for certain health-care transactions be sent to the state attorney general and kept confidential; LD2201 creates a review process for 'material change transactions' and protects proprietary submissions and certain identifiers. Both votes were unanimous among members present.

The joint Judiciary committee voted unanimously to approve proposed confidentiality provisions attached to two bills aimed at improving state oversight of health-care transactions.

Janet Stocco presented LD2202, which would require that health-care entities file the same pre-merger notice they send under the federal Hart-Scott-Rodino process with Maine's Attorney General. The amendment treats the state filing as confidential, with limited exceptions: the attorney general may disclose materials subject to a court or agency protection order, share information with the U.S. Department of Justice or the Federal Trade Commission, or disclose materials to another state attorney general subject to notice to the health-care entity. Committee members discussed federal-exemption analogies and retention considerations and then moved and seconded a motion that the proposed public-records exception meets the statutory criteria. The committee approved the motion unanimously among the eight members present.

The committee then reviewed LD2201 (committee amendment), which would require notice, review and, where necessary, a comprehensive review of "material change transactions" in which private-equity firms, hedge funds, or management-service organizations acquire control or operational control of health-care entities. The bill gives the Department of Health and Human Services and the Office of Affordable Health Care authority to request extensive cost- and market-impact information and to keep proprietary materials confidential; it also directs that the Maine Health Data Organization (MHDO) continue to make ownership data public while protecting taxpayer-identification numbers or Social Security numbers that are not otherwise public. The Office of Affordable Health Care's final report and determinations would be posted publicly, while drafts and preparatory work product could be kept confidential. Committee members asked about processes for designating proprietary information; staff said submitters would claim confidentiality and agencies would make determinations under the usual FOA procedures.

Both items were presented by staff as mirroring federal practice or established confidentiality approaches used by other agencies. Members asked about retention schedules (one member referenced a 75-year federal retention baseline) and whether the public would still get key outcome information; staff said the bills require posting of substantial public information (including final reports) while protecting genuinely proprietary data.

Both motions to find the proposed public-records exceptions met the statutory criteria were approved by voice or show-of-hands votes and recorded as unanimous among those present.

What happens next: The Judiciary committee recorded unanimous forward-review recommendations for LD2202 and LD2201; the originating committees and bill sponsors will receive the committee's report and confidentiality findings. The measures (or related language) may be considered later in the legislative process.